OKTO Continues Aggressive Expansion of U.S. and Global Surgical
COSTA MESA, California – 15 May 2003 –
OKTO Ophtho, the premier developer and distributor of specialty technologies
for eye surgery, continues its aggressive expansion of both its U.S.
Surgical Sales Team and its international distribution network.
surgical sales force is now the strongest and most focused in company
history,” said Erik Melling, Vice President of Sales of OKTO
Ophtho. “Expanding our presence in the U.S. with quality representation
has always been a priority. This is definitely the finest team of
surgical reps I have worked with and I know that they will provide
only the best service to ophthalmology O.R.s throughout the U.S.”
OKTO Ophtho is proud to announce the following surgical representation
appointments in United States territories:
Stan Durham / North Carolina
John Deeds / Alabama
Jason Speerly (ABS Medical) / Chicago
Erik Custardo (ABS Medical) / Chicago
Michael Limoni (ABS Medical) / Midwest
Jack Fitzsimmons / Iowa
OKTO has teamed with Susan Thomas of Export Associates to expand
the company’s international client and revenue base.
The company’s alliance with Susan Thomas and Export Associates
will allow the company and international customers to benefit from
Susan’s sales and surgical expertise on an international level.
Her main responsibility is the appointment and management international
distribution. Susan Thomas began her international sales and marketing
career over 25 years ago and has been dedicated to the marketing
and selling of ophthalmic devices since 1988.
“The relationships Susan has forged with ophthalmic international
distribution companies are strongest we’ve seen amongst international
consulting companies”, states Mr. Melling. “We are proud
to have Susan on our team and as our point-person with our international
Founded in 2000, OKTO Ophtho develops and commercializes specialized,
leading-edge surgical technologies for eye surgery. OKTO’s
purpose is to develop surgical solutions that improve the quality
of life for patients, elevate the performance and productivity of
eye care professionals, and lower costs to the provider.
OKTO currently holds leadership positions with surgical devices
for oculoplastic surgeries and bio-implant technologies for ocular